Literature DB >> 15741784

Psychotropic co-medication among stimulant-treated children in The Netherlands.

Adrianne Faber1, Lolkje T W de Jong-van den Berg, Paul B van den Berg, Hilde Tobi.   

Abstract

OBJECTIVES: The aim of this study was to examine stimulant use from 1998 to 2002 among children in the Dutch pediatric population with emphasis on psychotropic co-medication.
METHODS: A drug utilization study was based on community pharmacy-dispensing data from 1998 to 2002 for children aged 0-19 years in the northern and eastern part of The Netherlands.
RESULTS: The prevalence of stimulant use increased from 0.6% in 1998 to 1.2% in 2002. Duration of stimulant treatment was longest in children aged 5-14 years. The use of any psychotropic co-medication in stimulant users increased from 12% in 1998 to nearly 15% in 2002. Of those youths who were prescribed stimulant medication in 2002, the most co-prescribed class was the antipsychotics (7.9%). In 1998, none of the stimulant-treated children received antidepressants for co-medication; in 2002, this was 1.8%.
CONCLUSION: The prevalence of stimulant use among children in The Netherlands has increased in recent years, mainly as a result of the duration of stimulant treatment. Psychotropic co-medication among stimulant-treated children increased moderately.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741784     DOI: 10.1089/cap.2005.15.38

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  7 in total

1.  Use of double-blind placebo-controlled N-of-1 trials among stimulant-treated youths in The Netherlands: a descriptive study.

Authors:  Adrianne Faber; Ron J Keizer; Paul B van den Berg; Lolkje T W de Jong-van den Berg; Hilde Tobi
Journal:  Eur J Clin Pharmacol       Date:  2006-11-18       Impact factor: 2.953

2.  Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013.

Authors:  Hélène Verdoux; Elodie Pambrun; Sébastien Cortaredona; Marie Tournier; Pierre Verger
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01-07       Impact factor: 4.785

Review 3.  Research in child and adolescent psychopharmacology: recent accomplishments and new challenges.

Authors:  Benedetto Vitiello
Journal:  Psychopharmacology (Berl)       Date:  2006-05-23       Impact factor: 4.530

4.  Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.

Authors:  Els F van den Ban; Patrick C Souverein; Herman van Engeland; Hanna Swaab; Toine C G Egberts; Eibert R Heerdink
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-28       Impact factor: 4.328

5.  Prevalence and patterns of methylphenidate use in French children and adolescents.

Authors:  Anne-Laure Knellwolf; Jean Deligne; Flavia Chiarotti; Guy-Robert Auleley; Serena Palmieri; Claudine Blum Boisgard; Pietro Panei; Elisabeth Autret-Leca
Journal:  Eur J Clin Pharmacol       Date:  2007-11-20       Impact factor: 2.953

6.  Prescription drug dispensing profiles for one million children: a population-based analysis.

Authors:  Tingting Zhang; M Anne Smith; Pat G Camp; Salomah Shajari; Stuart M MacLeod; Bruce C Carleton
Journal:  Eur J Clin Pharmacol       Date:  2012-07-12       Impact factor: 2.953

Review 7.  Current issues around the pharmacotherapy of ADHD in children and adults.

Authors:  Willemijn M Meijer; Adrianne Faber; Els van den Ban; Hilde Tobi
Journal:  Pharm World Sci       Date:  2009-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.